1) active chemotherapy
主动化疗
2) active therapy
主动疗法
3) intra-arterial chemotherapy
动脉化疗
1.
The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer;
保留膀胱手术联合动脉化疗治疗浸润性膀胱癌的临床研究
2.
Method: 156 cancer patients with an indication of intra-arterial chemotherapy were randomly divided into two groups, 78 cases each receiving cisplatin (≥50mg/m2) and doxorubicin (≥40 mg/m2) respectively in the therapy scheme.
入选病例为具备介入动脉化疗或(和)栓塞治疗适应证且化疗方案中均含有顺铂≥50mg/m~2或(和)阿霉素≥40mg/m~2(吡喃阿霉素≥40mg/m~2,表阿霉素≥80mg/m~2)化疗药物。
3.
Several studies indicates that gemcitabine based intra-arterial chemotherapy may be effective in treating advanced pancreatic cancer.
动脉化疗可以通过对肿瘤动脉的局部灌注使肿瘤组织有较高的药物分布,有研究表明吉西他滨联合药物动脉化疗可能对晚期胰腺癌有效。
4) Arterial chemotherapy
动脉化疗
1.
To investigate the influence of preoperative arterial chemotherapy on the expression of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer.
[目的]探讨术前动脉化疗对膀胱癌p53和增殖细胞核抗原(PCNA)表达的影响及临床意义。
5) Chemotherapy
[英][,ki:məʊ'θerəpi] [美]['kimo'θɛrəpɪ]
动脉化疗
1.
To investigate the effect of systematic chemotherapy combined with Aidi injection transhepatic arterial infusion in treatment for liver cancer.
其中,A组51例周围静脉化疗,B组51例肝动脉化疗,C组52例化疗联合艾迪注射液肝动脉灌注。
6) Artery chemotherapy
动脉化疗
1.
Objective To find out how to choose the doses of hepatic artery chemotherapy(HAC)in hepatic cell carcinoma(HCC) cases with abnormal liver function.
目的 探讨肝功异常的原发性肝癌如何选择动脉化疗剂量。
2.
Then artery chemotherapy was done regularly.
方法：对9例胃癌、结直肠癌肝转移患者行左锁骨下动脉双管置入,行规律动脉化疗。
补充资料：恶性滋养细胞肿瘤终止化疗的指征
恶性滋养细胞肿瘤终止化疗的指征
恶性滋养细胞肿瘤经过化疗后，由于目前尚无很好方法测出体内有无残存瘤细胞、HCG放射免疫测定虽然比较灵敏，但也很难达到查出少量残存瘤细胞的目的，为此，治疗持续到达临床完全恢复的标准(即肺及子宫内转移灶完全消失，血或尿内HCG正常，临床无症状)，还需再巩固1～2个疗程，方可停药观察，病情无变化才能出院，以后继续随访。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条